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Abstract 
 
There were approximately 43,000 new cases of pancreatic ductal adenocarcinoma (PDAC) in 
the U.S. in 2010, and approximately 37,000 deaths. PDAC thus constitutes the fourth leading 
cause of cancer deaths, and PDAC patients have a dismal 5-year survival rate of 6%. PDAC is 
notoriously resistant to chemotherapy and radiation and even with our best treatment options, a 
complete margin-negative surgical resection, few patients achieving long-term survival.  Despite 
these statistics, surprisingly only a small number of NCI-designated cancer centers have a 
specialized pancreatic cancer program. The creation of the IUPUI Signature Center for 
Pancreatic Cancer Research has been the foundation for putting IUPUI, the IU School of 
Medicine, Purdue University and the IU Simon Cancer Center at the forefront of pancreatic 
cancer treatment and research across the nation. The Signature Center, comprised of basic, 
translational and clinical researchers, represents the continuum of the disease from biological / 
molecular investigation to clinical trials. Funding from the Signature Center Initiative is being 
utilized to develop genetically engineered mouse models, orthotopic pancreatic cancer models 
as well as a human pancreatic cancer xenograft model.  Establishment and characterization of 
these in vivo models provides the groundwork to be used by all members in their translational 
research projects.  Additionally, work has begun on a web portal to promote and educate both 
patients and clinicians about the IUSCC Pancreas Cancer Clinic which became operational in 
2010.  Taken together the development of these in vivo models as well as web support of the 
Pancreas Cancer Clinic provides the infrastructure to support pancreas cancer research across 
the continuum of bench to bedside to practice.  The availability of these resources to all 
members promotes inter-disciplinary collaborations aimed at increasing our understanding of 
pancreatic cancer so that advancements can be made in diagnosis, prevention and treatment of 
this malignancy.     
 
